CDC Strangle Strategy
CDC (VictoryShares US EQ Income Enhanced Volatility Wtd ETF), in the Financial Services sector, (Asset Management - Income industry), listed on NASDAQ.
The VictoryShares US EQ Income Enhanced Volatility Wtd ETF aims to mirror the investment outcomes of the Nasdaq Victory US Large Cap High Dividend 100 Long/Cash Volatility Weighted Index (referred to as the "Long/Cash Index"), prior to the deduction of fees and expenses. This fund utilizes a distinctive "Volatility Weighting" approach, which integrates fundamental criteria with volatility-based weighting in an effort to achieve superior performance compared to conventional market-capitalization-weighted index strategies. A key characteristic of the Long/Cash Index is its adaptive mechanism for equity exposure: it strategically diminishes its stock market presence during significant downturns and then re-enters the market as prices continue to fall or show signs of recovery. The index's rebalancing decisions are predicated on the month-end value of the Nasdaq Victory US Large Cap High Dividend 100 Volatility Weighted Index (the "Reference Index") relative to its All-Time Highest Daily Closing Value (AHDCV), which represents the peak daily closing price recorded by the Reference Index since its inception.
CDC (VictoryShares US EQ Income Enhanced Volatility Wtd ETF) trades in the Financial Services sector, specifically Asset Management - Income, with a market capitalization of approximately $720.2M, a beta of 0.34 versus the broader market, a 52-week range of 63.433-75.35, average daily share volume of 17K, a public-listing history dating back to 2014. These structural characteristics shape how CDC etf options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.34 indicates CDC has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. CDC pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a strangle on CDC?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current CDC snapshot
As of June 29, 2026, spot at $74.93, ATM IV 22.60%, IV rank 29.32%, expected move 6.48%. The strangle on CDC below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.
Why this strangle structure on CDC specifically: CDC IV at 22.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a CDC strangle, with a market-implied 1-standard-deviation move of approximately 6.48% (roughly $4.85 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CDC expiries trade a higher absolute premium for lower per-day decay. Position sizing on CDC should anchor to the underlying notional of $74.93 per share and to the trader's directional view on CDC etf.
CDC strangle setup
The CDC strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CDC near $74.93, the first option leg uses a $78.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CDC chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CDC shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $78.00 | $0.47 |
| Buy 1 | Put | $71.00 | $0.27 |
CDC strangle risk and reward
- Net Premium / Debit
- -$74.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$74.00
- Breakeven(s)
- $70.26, $78.74
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
CDC strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on CDC. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$7,025.00 |
| $16.58 | -77.9% | +$5,368.37 |
| $33.14 | -55.8% | +$3,711.73 |
| $49.71 | -33.7% | +$2,055.10 |
| $66.28 | -11.6% | +$398.47 |
| $82.84 | +10.6% | +$410.17 |
| $99.41 | +32.7% | +$2,066.80 |
| $115.97 | +54.8% | +$3,723.43 |
| $132.54 | +76.9% | +$5,380.07 |
| $149.11 | +99.0% | +$7,036.70 |
When traders use strangle on CDC
Strangles on CDC are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CDC chain.
CDC thesis for this strangle
The market-implied 1-standard-deviation range for CDC extends from approximately $70.08 on the downside to $79.78 on the upside. A CDC long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current CDC IV rank near 29.32% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CDC at 22.60%. As a Financial Services name, CDC options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CDC-specific events.
CDC strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CDC positions also carry Financial Services sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CDC alongside the broader basket even when CDC-specific fundamentals are unchanged. Always rebuild the position from current CDC chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on CDC?
- A strangle on CDC is the strangle strategy applied to CDC (etf). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With CDC etf trading near $74.93, the strikes shown on this page are snapped to the nearest listed CDC chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are CDC strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the CDC strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 22.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$74.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CDC strangle?
- The breakeven for the CDC strangle priced on this page is roughly $70.26 and $78.74 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CDC market-implied 1-standard-deviation expected move is approximately 6.48%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on CDC?
- Strangles on CDC are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CDC chain.
- How does current CDC implied volatility affect this strangle?
- CDC ATM IV is at 22.60% with IV rank near 29.32%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.